Editorial: Precision medicine for antithrombotic therapy in patients after percutaneous coronary interventions

Frontiers in Cardiovascular Medicine

Cardiovascular Medicine

Francesco Costa¹  Mattia Galli²  Dominick J. Angiolillo³ 

[1] Department of Biomedical and Dental Sciences and Morphological and Functional Imaging, University of Messina, Messina, Italy;Department of Cardiology, Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy;Division of Cardiology, University of Florida College of Medicine, Jacksonville, FL, United States;

关键词: precision medecine;    antithrombic agent;    antiplatelet therapy;    percutaneous coronary intervention;    anticoagulant;    P2Y12 inhibitors;   

DOI  :  10.3389/fcvm.2023.1162630

 received in 2023-02-09, accepted in 2023-02-15,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
© 2023 Galli, Costa and Angiolillo.